TIMOTHY KOWALESKI: Open Payments
NPI 1083093272 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,818 in 114 payments from 16 companies in 2025. Trend: 2023 $267 · 2024 $1,396 · 2025 $12,818
Speaker / faculty: $8,280Food & beverage: $1,845Travel & lodging: $1,793Consulting: $900
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 13 | $11,113 |
| Lundbeck LLC | 22 | $371 |
| ABBVIE INC. | 30 | $357 |
| Otsuka America Pharmaceutical, Inc. | 12 | $271 |
| Axsome Therapeutics, Inc. | 10 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $92 |
| Neurocrine BioSciences, Inc. | 4 | $85 |
| Indivior Inc. | 4 | $77 |
| Corium, LLC | 3 | $53 |
| Orexo US, Inc. | 3 | $47 |
Products named: VIVITROL, REXULTI, VRAYLAR, ABILIFY ASIMTUFII, Auvelity, CAPLYTA, INGREZZA, SUBLOCADE.
Industry payments across IN — which companies pay providers there.
